CDC issues New Clinical Practice Guidelines for Prescribing Opioids for Pain
Provided by MCMS Administration
All healthcare providers should be aware of the new CDC guidelines which update the 2016 guidelines which focused on opioid use for pain management. The 2022 updates remove the 2016 thresholds for dose and quantity of opioid prescriptions. While it steers away from inflexible standards, the report includes useful recommendations and supporting rationale for treating […]
Read more
Important Information concerning Increasing Presence of Xylazine Exposure in Overdose Deaths
Provided by MCMS Administration
Xylazine is a non-opioid sedative analgesic used in veterinary medicine to calm and handle animals for diagnostic tests and for anesthesia and pain relief for animal surgeries. It is increasingly being detected in drug overdoses. In a national study, the presence of xylazine in overdose deaths grew nearly 20-fold between 2015-2020 (Friedman, et al., 2022). […]
Read more